Study links protein-coding gene to tumor development, activation of body’s natural immune defense against cancer
Researchers create a novel method of bioprinting neuron cells
15 September 2021Studying resistance to therapy in BRAF-mutated brain tumors
15 September 2021Study links protein-coding gene to tumor development, activation of body’s natural immune defense against cancer
Researchers from the Case Comprehensive Cancer Center uncovered the potentially important role of the protein-coding gene, MYO10, in tumor development and immune therapy response. Their findings were published today in Science Advances.
